Pfizer Inc logo

PFE - Pfizer Inc News Story

$39.19 -0.4  -1.0%

Last Trade - 06/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £160.37bn
Enterprise Value £180.40bn
Revenue £33.38bn
Position in Universe 40th / 6849

BRIEF-Oxford Says Risk Of Rare Blood Clotting Higher For COVID-19 Than For Vaccines

Thu 15th April, 2021 10:25am
April 15 (Reuters) - University of Oxford: 
    * OXFORD - REPORTED RISK OF RARE BLOOD CLOTTING KNOWN AS
CEREBRAL
VENOUS THROMBOSIS FOLLOWING COVID-19 INFECTION IS AROUND 100
TIMES GREATER THAN NORMAL
    * OXFORD - REPORTED RISK OF RARE BLOOD CLOTTING FOLLOWING
COVID-19
INFECTION IS SEVERAL TIMES HIGHER THAN IT IS POST-VACCINATION OR
FOLLOWING INFLUENZA
    * OXFORD UNIVERSITY- REPORT SAYS CVT IS MORE COMMON AFTER
COVID-19
THAN IN ANY OF COMPARISON GROUPS, WITH 30% OF THESE CASES
OCCURRING IN UNDER 30S
    * OXFORD - REPORT SAYS COMPARED TO AZ-OXFORD VACCINE, RISK
OF A
CVT FROM COVID-19 IS ABOUT 8 TIMES GREATER

Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.